Burcu Aslan-Candir - Publications

Defibrotide-Responsive Cutaneous Endothelial Injury Following Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Published: May 13, 2026

Impact of Dyslipidemia on Allogeneic Transplantation Outcomes and Cardiovascular Mortality in Patients with Acute Leukemias in the Post-Transplant Cyclophosphamide Era.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 11, 2026

Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey.

Journal: Journal of clinical medicine

Published: February 01, 2026

The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 24, 2025

Cholesterol Levels Are Not Associated with Peripheral Blood Stem Cell Mobilization in Healthy Donors.

Journal: Journal of clinical medicine

Published: June 06, 2025

Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting.

Journal: Journal of clinical medicine

Published: July 24, 2024

Evaluation of oral manifestations and head and neck lymphadenopathy in newly diagnosed acute leukemia patients.

Journal: Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry

Published: March 31, 2023

Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 12, 2022

Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 10, 2022